Mirum Pharmaceuticals, Inc.

MIRMNasdaq· Pharmaceutical Preparations

Price History

Revenue

$521.3M

▲ 54.7% YoY

Net Income

-$23.4M

▲ 73.4% YoY

EPS

$-0.47

▲ 74.6% YoY

Cash

$296.7M

▲ 33.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.